Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nova Eye Medical (AU:EYE)
ASX:EYE
Holding AU:EYE?
Track your performance easily
EYE Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.14 - AU$0.30
Previous CloseN/A
Volume155.74K
Average Volume (3M)129.64K
Market Cap
$40.09M
Enterprise ValueAU$47.54M
Total Cash (Recent Filing)$9.24M
Total Debt (Recent Filing)$99.00K
Price to Earnings (P/E)―
Beta-0.12
Next Earnings
Feb 20, 2025EPS Estimate
>-0.01Last Dividend Ex-Date
Jul 21, 2020Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding229,072,770
10 Day Avg. Volume69,632
30 Day Avg. Volume129,640
Standard Deviation0.21
R-Squared0.15
Alpha-0.00034
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.21
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.19
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.19
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nova Eye Medical News
PremiumCompany Announcements
Nova Eye Medical Announces Proposed Security Issuance
PremiumCompany Announcements
Nova Eye Medical Outlines Future Developments Amid Uncertainty
PremiumCompany Announcements
Nova Eye Medical Secures $6.6 Million for Global Expansion
PremiumCompany Announcements
Nova Eye Medical Reports Strong Sales Growth and Strategic Expansion
PremiumCompany Announcements
Nova Eye Medical Initiates Trading Halt for Capital Raising Announcement
PremiumCompany Announcements
Nova Eye Medical Announces Director’s Securities ChangePremiumCompany Announcements
Nova Eye Medical Issues New Performance Rights
PremiumCompany Announcements
Nova Eye Medical Updates on Director’s Securities ChangesOptions Prices
Currently, No data available
---
Ownership Overview
EYE FAQ
What was Nova Eye Medical’s price range in the past 12 months?
Nova Eye Medical lowest share price was AU$0.14 and its highest was AU$0.30 in the past 12 months.
What is Nova Eye Medical’s market cap?
Nova Eye Medical’s market cap is $40.09M.
When is Nova Eye Medical’s upcoming earnings report date?
Nova Eye Medical’s upcoming earnings report date is Feb 20, 2025 which is in 20 days.
How were Nova Eye Medical’s earnings last quarter?
Nova Eye Medical released its earnings results on Aug 25, 2024. The company reported -AU$0.014 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.014.
Is Nova Eye Medical overvalued?
According to Wall Street analysts Nova Eye Medical’s price is currently Overvalued.
Does Nova Eye Medical pay dividends?
Nova Eye Medical pays a Notavailable dividend of AU$0.135 which represents an annual dividend yield of N/A. See more information on Nova Eye Medical dividends here
What is Nova Eye Medical’s EPS estimate?
Nova Eye Medical’s EPS estimate is >-0.01.
How many shares outstanding does Nova Eye Medical have?
Nova Eye Medical has 229,072,770 shares outstanding.
What happened to Nova Eye Medical’s price movement after its last earnings report?
Nova Eye Medical reported an EPS of -AU$0.014 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Nova Eye Medical?
Currently, no hedge funds are holding shares in AU:EYE
---
Nova Eye Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:EYE Sentiment 96%
Sector Average 71%
Sector Average 71%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
―
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
-38.77%
Trailing 12-Months
Asset Growth
-1.24%
Trailing 12-Months
Company Description
Nova Eye Medical
Ellex Medical Lasers Ltd. engages in design and manufacture of ophthalmic laser and ultrasound systems used by ophthalmologists to diagnose and treat eye diseases. It operates through the following segments: Faster Growing (iTrack), Emerging (2RT), and Core Ophthalmic Mark (Lasers and Ultrasounds). The iTrack segment offers catheter device that dilates the ocular structures compromised by glaucoma. The 2RT segment includes patent-protected with significant lead on competition and a per-use recurring fee business model. The Lasers and Ultrasounds segment represents testimony to the strength of the Ellex brand and was driven by growth in sales of the high-margin Ellex Tango and Ellex Tango Reflex glaucoma lasers. The company was founded by Giuseppe Canala and Victor Previn in 1985 and is headquartered in Adelaide, Australia.
---
Technical Analysis
Ansell
―
Cochlear Limited
―
Opthea Limited
―
CSL
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
---